Alternative splicing in human cancer cells is modulated by the amiloride derivative 3,5‐diamino‐6‐chloro‐N‐(N‐(2,6‐dichlorobenzoyl)carbamimidoyl)pyrazine‐2‐carboxide-Reference-Cited by-同舟云学术

Alternative splicing in human cancer cells is modulated by the amiloride derivative 3,5‐diamino‐6‐chloro‐N‐(N‐(2,6‐dichlorobenzoyl)carbamimidoyl)pyrazine‐2‐carboxide

Published:2019-06-28 Issue:8 Volume:13 Page:1744-1762
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Lee Chien‐Chin¹,Chang Wen‐Hsin¹²,Chang Ya‐Sian¹³⁴,Yang Jinn‐Moon⁵⁶⁷,Chang Chih‐Shiang⁸,Hsu Kai‐Cheng⁹,Chen Yun‐Ti⁶,Liu Ting‐Yuan³,Chen Yu‐Chia³,Lin Shyr‐Yi²¹⁰¹¹,Wu Yang‐Chang¹²¹³¹⁴¹⁵,Chang Jan‐Gowth¹²³

Affiliation:

1. Epigenome Research Center China Medical University Hospital Taichung Taiwan

2. Department of Primary Care Medicine Taipei Medical University Hospital Taiwan

3. Department of Laboratory Medicine China Medical University Hospital Taichung Taiwan

4. Center for Precision Medicine China Medical University Hospital Taichung Taiwan

5. TIGP‐Bioinformatics Institute of Information Science Academia Sinica Taipei Taiwan

6. Institute of Bioinformatics and Systems Biology National Chiao Tung University Hsinchu Taiwan

7. Department of Biological Science and Technology National Chiao Tung University Hsinchu Taiwan

8. Graduate Institute of Pharmaceutical Chemistry China Medical University Taichung Taiwan

9. Graduate Institute of Cancer Molecular Biology and Drug Discovery College of Medical Science and Technology Taipei Medical University Taiwan

10. Department of General Medicine School of Medicine College of Medicine Taipei Medical University Taiwan

11. TMU Research Center of Cancer Translational Medicine Taipei Medical University Taiwan

12. Graduate Institute of Natural Products Kaohsiung Medical University Taiwan

13. Research Center for Natural Products and Drug Development Kaohsiung Medical University Taiwan

14. Department of Medical Research Kaohsiung Medical University Hospital Taiwan

15. Chinese Medicine Research and Development Center China Medical University Hospital Taichung Taiwan

Funder

China Medical University Hospital

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12524

Reference57 articles.

1. Structure-guided U2AF65variant improves recognition and splicing of a defective pre-mRNA

2. FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma

3. A slowly progressive mitochondrial encephalomyopathy widens the spectrum of AIFM1 disorders

4. Prohibitin 2 represents a novel nuclear AKT substrate during all‐ trans retinoic acid–induced differentiation of acute promyelocytic leukemia cells

5. Emetine Regulates the Alternative Splicing of Bcl-x through a Protein Phosphatase 1-Dependent Mechanism

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular biological role of epithelial splicing regulatory protein 1 in intrahepatic cholangiocarcinoma;Hepatology Research;2024-07-22

2. The nexus of long noncoding RNAs, splicing factors, alternative splicing and their modulations;RNA Biology;2023-11-28

3. Pharmacological activity and mechanism of pyrazines;European Journal of Medicinal Chemistry;2023-10

4. Comprehensive Analysis and Drug Modulation of Human Endogenous Retrovirus in Hepatocellular Carcinomas;Cancers;2023-07-18

5. Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas;Biomarker Research;2023-07-04